Transcriptome profiling to determine molecular mechanisms of acquired EGFR TKI resistance. Transcriptome profiling to determine molecular mechanisms of acquired EGFR TKI resistance

The goal of this study was to compare the transcriptome (RNA-seq) of EGFR TKI sensitive NSCLC cells with that of cells with acquired resistance to erlotinib. HCC827 and HCC4006 cells were continuously cultured in erlotinib until erlotinib resistant (ER) variants emerged. All ER variants were negative for T790M. RNA from parental and ER cells was isolated for transcriptomic profiling. RNA-seq analysis reveals that EGFR TKI resistance is associated with a mesenchymal gene expression signature. Overall design: RNA-seq on total RNA from EGFR mutant NSCLC cells with or without erlotinib resistance